Home
E-Submission
Sitemap
Contact Us
ABOUT
Aims and scope
About the journal
Editorial board
Best practice
Open access
Contact us
BROWSE ARTICLES
All issues
Current issue
Most read articles
Most download articles
Most cited articles
Search
Author index
EDITORIAL POLICY
Research and publication ethics
Advertising policy
FOR CONTRIBUTORS
Instructions for authors
Author’s checklist
Copyright transfer agreement
Article processing charge
Readership
E-submission
Search
Search
Page Path
HOME
Search
Review Article
신경면역질환에서의 리툭시맙을 이용한 치료
유일한
J Mult Scler Neuroimmunol.
2023;14(1):44-50. Published online June 30, 2023
DOI:
https://doi.org/10.59578/jmsni.2023.14.1.44
Full text
PubReader
ePub
PDF
Review Article
중증근무력증의 새로운 치료 약물들
김진희, 신하영
J Mult Scler Neuroimmunol.
2023;14(1):34-43. Published online June 30, 2023
DOI:
https://doi.org/10.59578/jmsni.2023.14.1.34
Full text
PubReader
ePub
PDF
Review Article
항수초희소돌기아교세포당단백질항체 관련 질환
권영남, 김성민
J Mult Scler Neuroimmunol.
2023;14(1):24-33. Published online June 30, 2023
DOI:
https://doi.org/10.59578/jmsni.2023.14.1.24
Cited By 1
Full text
PubReader
ePub
PDF
Review Article
시신경척수염범주질환의 단클론항체 치료
김우준
J Mult Scler Neuroimmunol.
2023;14(1):15-23. Published online June 30, 2023
DOI:
https://doi.org/10.59578/jmsni.2023.14.1.15
Full text
PubReader
ePub
PDF
Review Article
다발경화증 치료제로서의 브루톤타이로신인산화효소 억제제
신제영, 안석원
J Mult Scler Neuroimmunol.
2023;14(1):9-14. Published online June 30, 2023
DOI:
https://doi.org/10.59578/jmsni.2023.14.1.9
Full text
PubReader
ePub
PDF
Review Article
다발성경화증의 MRI 특징에 대한 이해: 2017 McDonald 진단 기준에 근거하여
양지원
J Mult Scler Neuroimmunol.
2023;14(1):1-8. Published online June 30, 2023
DOI:
https://doi.org/10.59578/jmsni.2023.14.1.1
Full text
PubReader
ePub
PDF
Neuroimage
ANCA관련혈관염 환자에서 일측성으로 우세하게 나타난 경수막염
성의현, 김영서
J Mult Scler Neuroimmunol.
2022;13(2):39-40. Published online December 31, 2022
PDF
Case Report
고용량 스테로이드로 치료한 무증상 COVID-19 감염 이후 파킨슨증
강유진, 구가은, 추이슬, 원문호, 박찬영
J Mult Scler Neuroimmunol.
2022;13(2):35-38. Published online December 31, 2022
PDF
Case Report
리툭시맙 치료로 호전된 재발 중추신경계원발혈관염 1예
김태영, 김용진, 김민, 전재현, 박현미, 신동훈, 양지원
J Mult Scler Neuroimmunol.
2022;13(2):30-34. Published online December 31, 2022
PDF
Review Article
자가면역결절병증
유현지, 신하영
J Mult Scler Neuroimmunol.
2022;13(2):23-29. Published online December 31, 2022
PDF
Brief Communication
비전형적인 신경성 식욕부진증으로 오인된 시신경척수염범주질환
이지원
J Mult Scler Neuroimmunol.
2022;13(1):19-21. Published online June 1, 2022
PDF
Brief Communication
COVID-19 감염 후 발생한 시신경염
손성연
J Mult Scler Neuroimmunol.
2022;13(1):16-18. Published online June 1, 2022
PDF
Case Report
코티코스테로이드 투여에 임상적 효과를 보인 만성염증축삭 다발신경병증
양지원
J Mult Scler Neuroimmunol.
2022;13(1):12-15. Published online June 1, 2022
PDF
Case Report
뇌수막염으로 나타난 Neuro-Sweet 증후군
이빛나
J Mult Scler Neuroimmunol.
2022;13(1):8-11. Published online June 1, 2022
PDF
Review Article
COVID-19에 의한 신경계 증상과 기전
이진형, 허소영
J Mult Scler Neuroimmunol.
2022;13(1):1-7. Published online June 1, 2022
PDF
1
2
3
4
5
6
7
8
9
10
Journal of Multiple
Sclerosis and
Neuroimmunology
Print ISSN: 2733-8290
Online ISSN: 2951-2972
MOST VIEWED
MOST CITED
6,065
Autoimmune Nodopathy: When to Suspect and How to Treat?
5,221
National Consensus Guidance for Management of Refractory Myasthenia Gravis
3,911
The Clinical Utility of the Ocrelizumab for the Patients with Multiple Sclerorsis
2,942
Monoclonal Antibody Treatment for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder
2,851
Clinicoradiological Factors for Predicting and Monitoring the Progression of Multiple Sclerosis
+more
Cited By
3
National Consensus Guidance for Management of Refractory Myasthenia Gravis
Cited By
1
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis
Cited By
1
Collaboration between Medical Association and Patient Organizations to Overcome Rare Neurological Disorders
Cited By
1
Ocrelizumab's Place in the Therapeutic Landscape at its 2019 Launch in France
+more